Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Miscellaneous
  4. RMT/RMM presentation by MSLs
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

RMT/RMM presentation by MSLs

Scheduled Pinned Locked Moved Miscellaneous
5 Posts 2 Posters 133 Views 2 Watching
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • H Offline
    H Offline
    HollyMed
    wrote on last edited by
    #1

    Hello,
    It is possible for an RMT/RMM to be in the form of a non-promotional slide deck that is presented to HCPs by MSLs?
    Can the RMT include study data that supports the risk information assuming that there are no claims of benefit?

    1 Reply Last reply
    0
    • H Offline
      H Offline
      HollyMed
      wrote last edited by
      #2

      Just wondering if this question is appropriate for the forum. Please let me know if I should ask another way.

      1 Reply Last reply
      0
      • Jennifer CarrollJ Offline
        Jennifer CarrollJ Offline
        Jennifer Carroll
        wrote last edited by
        #3

        Sorry @HollyMed this one slipped through the cracks.

        Per the RMT guidance document, if the piece is intended to be detailed by a rep to an HCP, it requires going through the standard PAAB review process (i.e. the piece would be subject to all PAAB Code provisions relating to APS). Presentation of the safety data would be subject to the requirements of the PAAB Code. Give the above document a read and this Q&A and let us know if they answer is still unclear.

        1 Reply Last reply
        0
        • H Offline
          H Offline
          HollyMed
          wrote last edited by
          #4

          Thank you for your reply @Jennifer-Carroll. The document and the Q&A were helpful. I think the difference in my question is that an MSL would speak to the piece instead of a sales rep. Since MSLs do non-promotional activity, I would think that it would be okay for an MSL to speak to the RMT. Regarding the study data about risks, I would think that would be okay too assuming the at the study explores the risks associated with the product and that the study results are presented non-promotionally and do not point to a perceived benefit.

          1 Reply Last reply
          0
          • Jennifer CarrollJ Offline
            Jennifer CarrollJ Offline
            Jennifer Carroll
            wrote last edited by
            #5

            Hi @HollyMed

            While this activity would be acceptable, the RMM/RMT requires PAAB review. MSLs are representatives of a company that has a vested interest in the health product. Having an MSL detail to an RMT renders the activity subject to advertising regulations. This amplification context differs from a reactive interaction, largely driven by the HCP, in which the MSL responds to an HCP’s one-on-one inquiries. As a reminder, Health Canada’s policy document “The Distinction Between Advertising and Other Activities” emphasizes that the determination of “advertising” versus “non-advertising/promotion” depends on the nature of the activity itself rather than on job titles assigned by the sponsor.

            Regarding the second part, data presentations are not automatically compliant with advertising regulations simply because they pertain to risk. Compliance depends on multiple factors including (but not limited to) completeness, significance, context, and selectivity. Even data presented in a neutral tone can mislead if not balanced or contextualized appropriately. While the activity itself can be permissible, the slides require PAAB preclearance per the PAAB Code.

            1 Reply Last reply
            0
            Reply
            • Reply as topic
            Log in to reply
            • Oldest to Newest
            • Newest to Oldest
            • Most Votes


            • Login

            • Don't have an account? Register

            • Login or register to search.
            • First post
              Last post
            0
            • Categories
            • Recent
            • Tags
            • Popular
            • Users
            • Groups